| # | Drug | Count |
|---|---|---|
| 0 | LEUPROLIDE ACETATE | 7914 |
| 1 | USTEKINUMAB | 2296 |
| 2 | OCTREOTIDE ACETATE | 641 |
| 3 | RISPERIDONE | 632 |
| 4 | GUSELKUMAB | 542 |
| 5 | PALIPERIDONE PALMITATE | 371 |
| 6 | GOLIMUMAB | 306 |
| 7 | OMALIZUMAB | 295 |
| 8 | CERTOLIZUMAB PEGOL | 279 |
| 9 | ARIPIPRAZOLE | 198 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | HUMAN RHO(D) IMMUNE GLOBULIN | 155 | 0.1509 |
| 1 | LEUPROLIDE ACETATE | 7914 | 0.1012 |
| 2 | AVACINCAPTAD PEGOL | 18 | 0.0511 |
| 3 | ARIPIPRAZOLE LAUROXIL | 174 | 0.0378 |
| 4 | TRIPTORELIN | 90 | 0.0268 |
| 5 | GOLIMUMAB | 306 | 0.0243 |
| 6 | USTEKINUMAB | 2296 | 0.0223 |
| 7 | OCTREOTIDE ACETATE | 641 | 0.0209 |
| 8 | TRIPTORELIN PAMOATE | 37 | 0.0142 |
| 9 | GUSELKUMAB | 542 | 0.0142 |
| # | Drug class | Count |
|---|---|---|
| 0 | Interleukin-23 Antagonist [EPC] | 2856 |
| 1 | Interleukin-12 Antagonist [EPC] | 2297 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 664 |
| 3 | Anti-IgE [EPC] | 295 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 276 |
| 5 | Corticosteroid [EPC] | 266 |
| 6 | Human Immunoglobulin G [EPC] | 243 |
| 7 | Provitamin D2 Compound [EPC] | 196 |
| 8 | Interleukin-6 Receptor Antagonist [EPC] | 190 |
| 9 | Benzodiazepine [EPC] | 187 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-23 Antagonist [EPC] | 2856 | 0.0273 |
| 1 | Interleukin-12 Antagonist [EPC] | 2297 | 0.0221 |
| 2 | Polymyxin-class Antibacterial [EPC] | 1 | 0.0137 |
| 3 | Human Immunoglobulin G [EPC] | 243 | 0.0115 |
| 4 | Interleukin-5 Antagonist [EPC] | 7 | 0.0102 |
| 5 | Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC] | 18 | 0.0100 |
| 6 | Endoglycosidase [EPC] | 16 | 0.0086 |
| 7 | GLP-2 Analog [EPC] | 90 | 0.0067 |
| 8 | Provitamin D2 Compound [EPC] | 196 | 0.0066 |
| 9 | Sucrose-specific Enzyme [EPC] | 1 | 0.0055 |